<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01497639</url>
  </required_header>
  <id_info>
    <org_study_id>760906</org_study_id>
    <nct_id>NCT01497639</nct_id>
  </id_info>
  <brief_title>Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for Pallidal Deep Brain Stimulation</brief_title>
  <official_title>Comparison of the Efficacy of Double Monopolar Versus Interleaving Stimulation Modes for the Deep Brain Stimulation Treatment of Primary Generalized or Segmental Dystonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pecs</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pecs</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the efficacy and the safety profile of the newly
      introduced interleaving stimulation mode to those of the standard double monopolar
      stimulation mode during pallidal deep brain stimulation of primary generalized or segmental
      dystonia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      For the treatment of drug-refractory dystonia, bilateral pallidal deep brain stimulation
      (GPi-DBS) is proven to be an efficient option. On average, 40-55% improvement on dystonia
      rating scales (DRS) could be achieved according to the results of multicenter trials lasting
      for years. However, a considerable portion (10-25%) of the patients experience minimal
      alleviation despite of good electrode placement. These patients can be regarded as
      non-responders to GPi-DBS defined as having either limited improvement (&lt; 25% on DRS) or
      worsening. Besides adjusting the amplitude, frequency or pulse-width of stimulation, one can
      change the electrode configuration from the commonly applied single monopolar stimulation
      mode (one contact on the electrode is negative) to either double monopolar stimulation (two
      -usually adjacent- negative contacts on the electrode are stimulated with same amplitude and
      pulse-width values) or bipolar stimulation mode (one contact on the electrode is positive) in
      case of unsatisfactory outcomes. Although these techniques had been utilized in multicenter
      trials, non-responsiveness to GPi-DBS did occur. Recently the investigators have reported in
      the Movement Disorders that the newly introduced interleaving stimulation mode was superior
      to single or double monopolar stimulation in four patients who had initially (6-12 months
      after implantation) limited response to GPi DBS.

      Aims of the study:

      To systematically compare the efficacy and the side-effect profile of double monopolar
      stimulation mode to those of interleaving stimulation mode in a prospective, randomized,
      double-blind, and cross-over study.

      Methods:

      The investigators would enroll 20-25 patients with drug refractory segmental or generalized
      primary dystonia undergoing bilateral GPi-DBS implantation within a 2-3 year time frame. The
      inclusion and exclusion criteria would follow those of the study of Kupsch et al.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in severity of dystonia</measure>
    <time_frame>7 months</time_frame>
    <description>Differences in severity of dystonia measured by Burke-Fahn-Marsden Dystonia Rating Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of treatment responders after three months deep brain stimulation</measure>
    <time_frame>7 months</time_frame>
    <description>Differences in number of treatment responders (at least 25% improvement on Burke-Fahn-Marsden Dystonia Rating Scale compared to baseline)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life after three months deep brain stimulation</measure>
    <time_frame>7 months</time_frame>
    <description>Differences in health-related quality of life measured by EQ-5D and SF-36 scales</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side-effect profile after three months deep brain stimulation</measure>
    <time_frame>7 months</time_frame>
    <description>Differences in side-effect profile measured by stuctured deep brain stimulation-related side-effect questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Primary Dystonia</condition>
  <arm_group>
    <arm_group_label>Process 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Visit 1: Baseline evaluation (maximum 1 week before operation)
Visit 2: Testing of electrodes and subsequent initiation of interleaving stimulation mode (4th postoperative week).
Visit 3 Evaluation and cross-over to double-monopolar stimulation mode (16th postoperative week).
Visit 4 Final evaluation. (28th postoperative week).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Process 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Visit 1: Baseline evaluation (maximum 1 week before operation)
Visit 2: Testing of electrodes and subsequent initiation of double-monopolar stimulation mode (4th postoperative week).
Visit 3 Evaluation and cross-over to interleaving stimulation mode (16th postoperative week).
Visit 4 Final evaluation. (28th postoperative week).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Interleaving stimulation mode (Medtronic)</intervention_name>
    <description>Interleaving stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Interleavingr stimulation mode (Medtronic)'</description>
    <arm_group_label>Process 1</arm_group_label>
    <arm_group_label>Process 2</arm_group_label>
    <other_name>Medtronic Activa RC Interleaving Stimulation Mode</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Double monopolar stimulation mode (Medtronic)</intervention_name>
    <description>Double monopolar stimulation mode with constant frequency (125 Hz) and pulse-width (120us)parameters 'Double monopolar stimulation mode (Medtronic)'</description>
    <arm_group_label>Process 1</arm_group_label>
    <arm_group_label>Process 2</arm_group_label>
    <other_name>Medtronic Activa RC Double Monopolar Stimulation Mode</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ages of 7 and 75 years

          -  marked disability owing to primary generalized or segmental dystonia, despite optimal
             pharmacologic treatment

          -  disease duration of at least 5 years.

        Exclusion Criteria:

          -  previous brain surgery;

          -  cognitive impairment (&lt; 120 points on the Mattis Dementia Rating Scale)

          -  moderate-to-severe depression (&gt; 25 points on the Beck Depression Inventory)

          -  marked brain atrophy as detected by magnetic resonance imaging

          -  other medical or psychiatric coexisting disorders that could increase the surgical
             risk or interfere with completion of the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Norbert Kovacs, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate professor, Department of Neurology, University of Pecs</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Norbert Kovacs, MD, PhD</last_name>
    <phone>+3672535910</phone>
    <email>kovacsnorbert06@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurology, University of Pécs</name>
      <address>
        <city>Pécs</city>
        <state>Baranya Megye</state>
        <zip>H-7623</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Kovacs, MD, PhD</last_name>
      <phone>+3672535910</phone>
      <email>kovacsnorbert06@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Norbert Kovacs, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <reference>
    <citation>Kupsch A, Benecke R, Müller J, Trottenberg T, Schneider GH, Poewe W, Eisner W, Wolters A, Müller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Vollmer-Haase J, Brentrup A, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Naumann M, Volkmann J; Deep-Brain Stimulation for Dystonia Study Group. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med. 2006 Nov 9;355(19):1978-90.</citation>
    <PMID>17093249</PMID>
  </reference>
  <reference>
    <citation>Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, Lagrange C, Tézenas du Montcel S, Dormont D, Grand S, Blond S, Detante O, Pillon B, Ardouin C, Agid Y, Destée A, Pollak P; French Stimulation du Pallidum Interne dans la Dystonie (SPIDY) Study Group. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005 Feb 3;352(5):459-67.</citation>
    <PMID>15689584</PMID>
  </reference>
  <reference>
    <citation>Valldeoriola F, Regidor I, Mínguez-Castellanos A, Lezcano E, García-Ruiz P, Rojo A, Salvador A, Castro A, Grandas F, Kulisevsky J, Martí MJ, Martínez-Martín P, Relova L, Rumià J, Cámara A, Burguera JA, Linazasoro G, de Val JL, Obeso J, Rodríguez-Oroz MC, Tolosa E; Grupo ESpañol para el EStudio de la EStimulación PALidal en la DIStonía. Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):65-9. doi: 10.1136/jnnp.2009.174342. Epub 2009 Sep 10.</citation>
    <PMID>19744963</PMID>
  </reference>
  <reference>
    <citation>Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Lagrange C, Yelnik J, Bardinet E, Benabid AL, Navarro S, Dormont D, Grand S, Blond S, Ardouin C, Pillon B, Dujardin K, Hahn-Barma V, Agid Y, Destée A, Pollak P; French SPIDY Study Group. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol. 2007 Mar;6(3):223-9.</citation>
    <PMID>17303528</PMID>
  </reference>
  <reference>
    <citation>Kupsch A, Tagliati M, Vidailhet M, Aziz T, Krack P, Moro E, Krauss JK. Early postoperative management of DBS in dystonia: programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting. Mov Disord. 2011 Jun;26 Suppl 1:S37-53. doi: 10.1002/mds.23624. Review.</citation>
    <PMID>21692111</PMID>
  </reference>
  <reference>
    <citation>Kovács N, Janszky J, Nagy F, Balás I. Changing to interleaving stimulation might improve dystonia in cases not responding to pallidal stimulation. Mov Disord. 2012 Jan;27(1):163-5. doi: 10.1002/mds.23962. Epub 2011 Sep 28.</citation>
    <PMID>21956680</PMID>
  </reference>
  <reference>
    <citation>Tagliati M, Krack P, Volkmann J, Aziz T, Krauss JK, Kupsch A, Vidailhet AM. Long-Term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations. Mov Disord. 2011 Jun;26 Suppl 1:S54-62. doi: 10.1002/mds.23535. Review.</citation>
    <PMID>21692113</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2011</study_first_submitted>
  <study_first_submitted_qc>December 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2011</study_first_posted>
  <last_update_submitted>October 30, 2016</last_update_submitted>
  <last_update_submitted_qc>October 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pecs</investigator_affiliation>
    <investigator_full_name>Dr. Norbert Kovacs</investigator_full_name>
    <investigator_title>Associate professor, specialist in neurology and movement disorders, Department of Neurology</investigator_title>
  </responsible_party>
  <keyword>dystonia</keyword>
  <keyword>pallidal stimulation</keyword>
  <keyword>deep brain stimulation</keyword>
  <keyword>deep brain stimulation of GPi</keyword>
  <keyword>GPi</keyword>
  <keyword>interleaving stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dystonia</mesh_term>
    <mesh_term>Dystonic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

